Manning & Napier Group's JNJ Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 147,340 shares of Johnson & Johnson (JNJ) worth $27.32 M, representing 0.35% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 1.11 M shares. Largest reduction occurred in Q3 2014, reducing 2.36 M shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +4.47 M | Add 0.00% | 4.47 M | $85.86 |
| Q3 2013 | -312,280 | Reduce 6.99% | 4.15 M | $86.69 |
| Q4 2013 | -20,304 | Reduce 0.49% | 4.13 M | $91.59 |
| Q1 2014 | +594,503 | Add 14.39% | 4.73 M | $98.23 |
| Q2 2014 | +42,091 | Add 0.89% | 4.77 M | $104.62 |
| Q3 2014 | -2.36 M | Reduce 49.48% | 2.41 M | $106.59 |
| Q4 2014 | -49,023 | Reduce 2.03% | 2.36 M | $104.57 |
| Q1 2015 | +441,739 | Add 18.71% | 2.8 M | $100.60 |
| Q2 2015 | +490,018 | Add 17.49% | 3.29 M | $97.46 |
| Q3 2015 | +1.11 M | Add 33.86% | 4.41 M | $93.35 |
| Q4 2015 | -636,962 | Reduce 14.45% | 3.77 M | $102.72 |
| Q1 2016 | -226,548 | Reduce 6.01% | 3.54 M | $108.20 |
| Q2 2016 | -245,448 | Reduce 6.93% | 3.3 M | $121.30 |
| Q3 2016 | -269,272 | Reduce 8.17% | 3.03 M | $118.13 |
| Q4 2016 | -85,637 | Reduce 2.83% | 2.94 M | $115.21 |
| Q1 2017 | -1.01 M | Reduce 34.31% | 1.93 M | $124.55 |
| Q2 2017 | -100,726 | Reduce 5.21% | 1.83 M | $132.29 |
| Q3 2017 | -54,208 | Reduce 2.96% | 1.78 M | $130.01 |
| Q4 2017 | +1.67 M | Add 0.00% | 1.67 M | $139.72 |
| Q1 2018 | -47,329 | Reduce 2.83% | 1.63 M | $128.15 |
| Q2 2018 | -7,141 | Reduce 0.44% | 1.62 M | $121.34 |
| Q3 2018 | +38,027 | Add 2.35% | 1.66 M | $138.17 |
| Q4 2018 | +252,348 | Add 15.23% | 1.91 M | $129.05 |
| Q1 2019 | +99,675 | Add 5.22% | 2.01 M | $139.79 |
| Q2 2019 | -22,661 | Reduce 1.13% | 1.99 M | $139.28 |
| Q3 2019 | +4,055 | Add 0.20% | 1.99 M | $129.38 |
| Q4 2019 | -31,058 | Reduce 1.56% | 1.96 M | $145.87 |
| Q1 2020 | -188,243 | Reduce 9.61% | 1.77 M | $131.13 |
| Q2 2020 | -19,113 | Reduce 1.08% | 1.75 M | $140.63 |
| Q3 2020 | -2,814 | Reduce 0.16% | 1.75 M | $148.88 |
| Q4 2020 | -52,138 | Reduce 2.98% | 1.7 M | $157.38 |
| Q1 2021 | +38,593 | Add 2.27% | 1.74 M | $164.35 |
| Q2 2021 | +41,695 | Add 2.40% | 1.78 M | $164.74 |
| Q3 2021 | +10,317 | Add 0.58% | 1.79 M | $161.50 |
| Q4 2021 | -22,081 | Reduce 1.24% | 1.76 M | $171.07 |
| Q1 2022 | -68,132 | Reduce 3.86% | 1.7 M | $177.23 |
| Q2 2022 | -83,184 | Reduce 4.90% | 1.61 M | $177.51 |
| Q3 2022 | -8,657 | Reduce 0.54% | 1.6 M | $163.36 |
| Q4 2022 | -43,085 | Reduce 2.68% | 1.56 M | $176.65 |
| Q1 2023 | +25,637 | Add 1.64% | 1.59 M | $155.00 |
| Q2 2023 | +105,357 | Add 6.64% | 1.69 M | $165.52 |
| Q3 2023 | -5,901 | Reduce 0.35% | 1.69 M | $155.75 |
| Q4 2023 | -62,582 | Reduce 3.71% | 1.62 M | $156.74 |
| Q1 2024 | -38,528 | Reduce 2.37% | 1.59 M | $158.19 |
| Q2 2024 | +1.57 M | Add 0.00% | 1.57 M | $146.16 |
| Q3 2024 | -20,916 | Reduce 1.33% | 1.55 M | $162.06 |
| Q4 2024 | -166,787 | Reduce 10.75% | 1.38 M | $144.62 |
| Q1 2025 | -217,885 | Reduce 15.74% | 1.17 M | $165.84 |
| Q2 2025 | -904,444 | Reduce 77.51% | 262,380 | $152.75 |
| Q3 2025 | -115,040 | Reduce 43.84% | 147,340 | $185.42 |
Manning & Napier Group's Johnson & Johnson Investment FAQs
Manning & Napier Group first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 4,465,276 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Johnson & Johnson (JNJ) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 4,465,276 shares worth $383.39 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 147,340 shares of Johnson & Johnson (JNJ), valued at approximately $27.32 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.35% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Johnson & Johnson (JNJ) was 4,769,286 shares, as reported at the end of Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.